Description
TB-500 is the name most commonly used within the research community for peptides derived from Thymosin β4 biology. This product contains the complete Thymosin β4 (1–43) sequence, allowing researchers to investigate the full endogenous peptide rather than a shortened derivative.
Product characteristics
| Specification | Details |
| Product | TB-500 (complete Thymosin β4 (1–43) sequence) |
| Quantity | 5 mg per vial |
| Form | Lyophilised powder |
| Purity | ≥99.54% (HPLC tested) |
| Molecular formula: | C212H350N56 O78S |
| Molecular weight | 4963.49 g/mol |
| CAS No | 77591-33-4 |
| Storage | Refrigerated at 2–8°C |
| Intended application | Laboratory and analytical research |
Quality control
Current batch: TB5-260415
- Internal HPLC purity: 99.54%
Further information
Thymosin β4 belongs to the healing & recovery peptide research cluster, focused on tissue signaling, cellular repair mechanisms, and inflammatory pathway modulation.
For broader context on regenerative pathways and compound interactions, see our Healing & recovery research guide.
For general laboratory preparation and handling, consult our Peptide Reconstitution Guide.
Disclaimer
This product is sold for research purposes only. It is not intended to diagnose, treat, cure, or prevent any disease. Buyer assumes full responsibility for proper handling and use.







